Tag Archives: ADXS

Friday’s Midday Movers: ImmunoCellular Therapeutics (IMUC), Rosetta Genomics Ltd (ROSG), Advaxis (ADXS), Idera (IDRA), Anthera Pharmaceuticals (ANTH)

So far Friday, December 14, NASDAQ is down -1% and the S&P is down -1.41%. Here are this morning’s most active stocks: ImmunoCellular Therapeutics (IMUC – Research Report), Rosetta Genomics Ltd (ROSG – Research Report), Advaxis (ADXS – Research Report),

A Director at Advaxis (NASDAQ: ADXS) is Buying Shares

Today, a Director at Advaxis (NASDAQ: ADXS), Roni Appel, bought shares of ADXS for $40K. This recent transaction increases Roni Appel’s holding in the company by 26.92% to a total of $128.4K. See today’s analyst top recommended stocks >> Currently,

Analysts Are Bullish on These Healthcare Stocks: ADXS, CCXI

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Advaxis (NASDAQ: ADXS) and ChemoCentryx (NASDAQ: CCXI) with bullish sentiments. Advaxis (NASDAQ: ADXS) In a report released today, Swayampakula Ramakanth from H.C.

Analysts Offer Insights on Healthcare Companies: Advaxis (NASDAQ: ADXS) and Nektar Therapeutics (NASDAQ: NKTR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Advaxis (NASDAQ: ADXS) and Nektar Therapeutics (NASDAQ: NKTR) with bullish sentiments. Advaxis (NASDAQ: ADXS) In a report released today, Swayampakula Ramakanth from

Cantor Fitzgerald Thinks Advaxis’ Stock is Going to Recover

Cantor Fitzgerald analyst Mara Goldstein maintained a Buy rating on Advaxis (NASDAQ: ADXS) today and set a price target of $19. The company’s shares opened today at $3, close to its 52-week low of $2.71. Goldstein noted: “Closing out 2017

Thursday’s Highlights at Noon: Acura Pharmaceuticals (ACUR), Cannabis Science Inc (CBIS), Aeterna Zentaris (AEZS), Advaxis (ADXS), Pengrowth Energy Corp (PGH)

So far Thursday, December 21, NASDAQ is down -0.34% and the S&P is up 0.2%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Acura Pharmaceuticals (NASDAQ:ACUR), Cannabis Science Inc (Other OTC:CBIS), Aeterna Zentaris